spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  sublingual 

 HSMN NewsFeed - 11 Jan 2022
Vivera Appoints Donald D'Ambrosio as Chief Financial Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 2 Jul 2020
Orexo Launches Deprexis(R) and Vorvida(R) in the US and Provides Updated Financial Guidance
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 29 May 2020
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Apr 2020
AcelRx Announces DSUVIA(R) Milestone C Approval and Provides Business Update
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 31 Mar 2020
Relmada Therapeutics Solidifies its R&D Leadership Team with the Appointment of Marc de Somer, MD, MBA, ScD, MPH, MSc, as Senior Vice President, Clinical Development and Safety
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2019
Braeburn Announces Publication of Phase 3 Study Results Showing Long-term Safety and Effectiveness of BRIXADI(TM) (buprenorphine) Extended-Release Injection for the Treatment of Opioid Use Disorder
Biopharmaceuticals
 HSMN NewsFeed - 22 Feb 2019
Mylan Launches Generic Suboxone(R) Sublingual Film to Treat Opioid Dependence
Biopharmaceuticals Drug Delivery Generics Product Launch
 HSMN NewsFeed - 26 Nov 2018
Biohaven Announces FDA Acceptance of 505(b)(2) NDA Filing for BHV-0223, a Novel Sublingual Delivery Form of Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology Drug Delivery FDA
 HSMN NewsFeed - 21 Sep 2018
CHMP Recommends Approval of Buvidal(R) (CAM2038) for the Treatment of Opioid Dependence
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Jun 2018
AcelRx receives European Commission approval for DZUVEO(TM)
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 14 May 2018
Aquestive Therapeutics Settles Patent Infringement Case with Par Pharmaceuticals
Biopharmaceuticals Drug Delivery Generics Litigation
 HSMN NewsFeed - 27 Apr 2018
AcelRx receives positive CHMP opinion for DZUVEO(TM) for management of acute moderate to severe pain in medically monitored settings
Biopharmaceutical Drug Delivery Regulatory
 HSMN NewsFeed - 14 Mar 2018
Pharmaceutical Startup, Bridge Therapeutics, Announces Tim Peara Will Be Joining the Company as the Director of Finance
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 21 Feb 2018
Pharmaceutical Startup, Bridge Therapeutics, Names David H. Bergstrom, Ph.D. as New Chief Operating Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 1 Aug 2017
AcelRx Pharmaceuticals Reports Successful Outcome of ZALVISO Phase 3 IAP312 Study on Device Functionality
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 19 Jul 2017
AcelRx Pharmaceuticals Appoints Raffi Asadorian as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2017
Braeburn Pharmaceuticals and Knight Therapeutics Announce Filing of New Drug Submission for PROBUPHINE(R) in Canada for Opioid Drug Dependence
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 5 Apr 2017
Therapix Signs Exclusive License Agreement with Yissum for Nasal Drug Delivery Technology
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 2 Mar 2017
ALK Announces FDA Approval for its House Dust Mite Sublingual Allergy Immunotherapy Tablet (ACARIZAX(R) in Europe)
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Feb 2017
AcelRx Pharmaceuticals Appoints Vincent J. Angotti Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jan 2017
Insys Therapeutics Announces Retirement of Dr. John N. Kapoor as CEO and Chairman; Appoints Dr. Santosh Vetticaden as Interim CEO and Steven Meyer as Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Dec 2016
Tonix Pharmaceuticals’ PTSD Phase 3-Ready Drug Candidate, TNX-102 SL, Granted Breakthrough Therapy Designation by the FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Dec 2016
Orexo Appeals Zubsolv(R) US District Court Decision
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 6 Oct 2016
U.S. FDA Approves Orexo's Low Dose ZUBSOLV(R) Buprenorphine and Naloxone Sublingual Tablets (CIII)
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Sep 2016
Insys Therapeutics Announces CEO Succession Plan
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Sep 2016
Lannett Announces Approval For Buprenorphine And Naloxone Sublingual Tablets, 2 mg/0.5 mg And 8 mg/2 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 1 Sep 2016
Sunovion Pharmaceuticals to Acquire Cynapsus Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Jul 2016
Insys Therapeutics Announces FDA Approval of Syndros(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Apr 2016
Braeburn Pharmaceuticals and Camurus Announce Enrollment Goals Reached in Two Pivotal Phase 3 Trials of Cam2038 for Treatment of Opioid Dependence
Biopharmaceuticals
 HSMN NewsFeed - 21 Jan 2016
AcelRx Pharmaceuticals Announces Presentation of Phase 3 Sufentanil Sublingual 30 mcg Tablet (ARX-04) Data at the European Congress of Ambulatory Surgery
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 19 Jan 2016
Akorn Launches Buprenorphine/Naloxone Sublingual Tablets and Tobramycin Injection
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 8 Jan 2016
AcelRx Completes Protocol Review with FDA and Plans to Initiate Phase 3 Open-Label Study (IAP312) for Zalviso(TM) in 1Q 2016
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Nov 2015
Insys Therapeutics Announces Senior Management Changes and Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2015
AcelRx Pharmaceuticals Appoints Gina Ford as Vice President Commercial Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Sep 2015
Espero Pharmaceuticals Announces Exclusive Licensing and Distribution Agreement
Biopharmaceuticals Drug Delivery Distribution
 HSMN NewsFeed - 4 Aug 2015
Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol for the Treatment of Infantile Spasms
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 29 Jul 2015
Galena Biopharma Launches Zuplenz(R) (ondansetron) Oral Soluble Film
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 24 Jul 2015
AcelRx Announces Positive CHMP Opinion for Zalviso in the Management of Acute Moderate-to-Severe Post-Operative Pain in Adult Patients
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 2 Jul 2015
Zalviso(TM) Phase 3 Orthopedic Results Published In Anesthesiology Demonstrate Significant Reductions In Post-Operative Pain
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 13 Mar 2015
Actavis Receives FDA Approval of SAPHRIS(R) for Pediatric Patients (age 10-17) for Acute Treatment of Manic or Mixed Episodes of Bipolar I Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Sep 2014
AcelRx Pharmaceuticals Provides Regulatory Update on Zalviso(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Aug 2014
Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Jul 2014
Mystic Pharmaceuticals Unveils The Next Generation Of Patient-Centric Sublingual Drug Delivery Devices
Biopharmaceuticlas Drug Delivery Product Launch
 HSMN NewsFeed - 2 Jul 2014
Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Dravet Syndrome, a Rare Form of Epilepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 3 Feb 2014
Merck Announces Canadian Approval of GRASTEK(R) (Standardized Allergenic Extract, Timothy Grass (Phleum pratense) Sublingual Tablet)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 14 Jan 2014
Ipsen and GW Pharmaceuticals plc Enter into Agreement for Ipsen to Promote and Distribute Sativex(R) in Latin America
Biopharmaceuticals Neurology Distribution
 HSMN NewsFeed - 13 Jan 2014
Insys Announces Details of Product Development Pipeline
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 16 Dec 2013
AcelRx and Grunenthal Announce Collaboration for EU Commercialization of ZALVISO(TM)
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 12 Dec 2013
Orexo Announces the Launch of Abstral(R) in Japan
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 2 Dec 2013
Forest to Acquire U.S. Marketing Rights to Saphris(R) (asenapine) from Merck
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 20 Aug 2013
Mallinckrodt Pharmaceuticals Signs Distribution Agreement with Amneal Pharmaceuticals LLC
Biopharmaceuticals Generics Distribution
 HSMN NewsFeed - 5 Jul 2013
U.S. FDA Approves Zubsolv(R) for the Maintenance Treatment of Opioid Dependence
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Apr 2013
NovaDel Announces the Signing of a Definitive Agreement to Sell its NovaMist(TM) Technology and Certain Other Assets
Biopharmaceuticals Drug Delivery Acquisitions
 HSMN NewsFeed - 5 Feb 2013
Orexo strengthens the commercial leadership structure and appoints Nikolaj Sørensen as new CEO and Martin Nicklasson as Executive Chairman
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 17 Dec 2012
Titan Pharmaceuticals Licenses Exclusive Probuphine(R) Commercialization Rights in U.S. and Canada to Braeburn Pharmaceuticals
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 14 Dec 2012
AcelRx to Present Top-Line Data from Phase 3 Study of Sufentanil NanoTab(R) PCA System vs. IV PCA Morphine at the 66th Annual PostGraduate Assembly in Anesthesiology held in New York City
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 20 Aug 2012
Reckitt Benckiser Pharmaceuticals Inc. Announces FDA Approval of Two New Dosage Strengths of Suboxone(R) Sublingual Film (C-III) for Maintenance Treatment of Opioid Dependence
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Jun 2012
Kedem Pharmaceuticals to Appoint New Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2012
Orexo acquires US commercial rights of Abstral and ProStrakan acquires the corresponding rights in the EU and rest of the world
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 5 Apr 2012
Transcept Pharmaceuticals Announces National Product Launch of Intermezzo(R) by Purdue Pharma L.P.
Biopharmaceuticals
 HSMN NewsFeed - 5 Jan 2012
INSYS Therapeutics Announces FDA Approval of SUBSYS(R) Fentanyl Sublingual Spray
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Dec 2011
INSYS Therapeutics Announces Addition of VP of Marketing to Commercial Team
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 17 Jun 2011
Titan Pharmaceuticals Provides Update on Confirmatory Phase 3 Study of Probuphine
Biopharmaceuticals
 HSMN NewsFeed - 14 Jan 2011
Orexo and Invida Jointly Announce Agreement for Abstral(TM) in Asia Pacific
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 10 Jan 2011
Orexo: FDA Approval For Abstral (Fentanyl) Sublingual Tablets - US Launch Planned For Q1 2011
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Jun 2010
Biodel Appoints Donald Casey, Jr. to Board of Directors
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 6 Apr 2010
AcelRx Pharmaceuticals Names Richard King Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 30 Mar 2010
Biodel Announces Senior Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Mar 2010
INSYS Therapeutics, Inc. Announces Positive Phase III Efficacy Trial Results for Fentanyl Sublingual Spray
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 22 Feb 2010
Transcept Pharmaceuticals Provides Update on Intermezzo(R) Regulatory Review
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Feb 2010
Orexo Announces That Partner Kyowa Hakko Kirin Entered a Joint Distribution Agreement on KW-2246 for Treatment of Cancer Pain in Japan
Biopharmaceuticals Distribution
 HSMN NewsFeed - 27 Nov 2009
STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 29 Oct 2009
Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Oct 2009
AcelRx Pharmaceuticals Hires Nigel Ray as Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Sep 2009
Schering-Plough Reports Data From SAPHRIS(R) (asenapine) Long-Term Schizophrenia Relapse Prevention Study
Biopharmaceuticals
 HSMN NewsFeed - 24 Jul 2009
SAPHRIS(R) (asenapine) Meets Primary Endpoint in Long-Term Extension Study in Patients With Predominant, Persistent Negative Symptoms of Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 2 Jun 2009
Schering-Plough Announces European Filing of SYCREST(R) (asenapine) for the Treatment of Schizophrenia and Bipolar I Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 16 Mar 2009
Orexo's Edluar (Sublinox) Receives FDA Approval for the Treatment of Insomnia
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Mar 2009
Orexo's AbstralTM Receives Two Further Large EU Market Approvals in France and Spain
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Feb 2009
Schering-Plough Submits Response to FDA for SAPHRIS(TM) (asenapine) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
Biopharmaceuticals
 HSMN NewsFeed - 2 Feb 2009
Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Jan 2009
Novacea Stockholders Approve Merger With Transcept
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Jan 2009
U.S. FDA Issues Complete Response Letter for SAPHRIS(TM) (ASENAPINE) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
Biopharmaceuticals
 HSMN NewsFeed - 22 Dec 2008
Prostrakan and Paladin Complete Agreement for Abstral(R) and Sancuso(R)
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 9 Dec 2008
AcelRx Pharmaceuticals Reports Positive Results From a Phase 2 Clinical Trial of Sublingual Sufentanil NanoTabs(TM) in Treating Post-Operative Pain
Biopharmaceuticals Pain Management
 HSMN NewsFeed - 22 Oct 2008
Clinical Study of Intermezzo(R) for the Treatment of Middle of the Night Awakening Published in SLEEP
Biopharmaceuticals
 HSMN NewsFeed - 1 Oct 2008
Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 26 Aug 2008
QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals Inc.
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 20 May 2008
Biodel Inc. Announces Appointment of Alan Krasner, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Apr 2008
Meda and Orexo in a Potential Billion SEK Deal
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 14 Mar 2008
Greer Launches Phase III Trial to Study Efficacy of Sublingual-Oral Immunotherapy in Patients with Allergic Rhinoconjunctivitis
Biopharmaceuticals
 HSMN NewsFeed - 7 Mar 2008
Orexo: Rapinyl(TM) has Received Swedish Marketing Authorization
Biopharmaceuticals Regulatory Drug Delivery
 HSMN NewsFeed - 12 Feb 2008
Sosei Announces Start of AD 923 Phase III Studies in Europe
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 28 Nov 2007
Sosei Announces Approval to Start AD 923 Phase III Studies in Europe
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 14 Nov 2007
Biodel Inc. Announces Appointment of Gerard Michel as CFO, VP of Corporate Development and Treasurer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Nov 2007
Study Shows Organon's Asenapine Demonstrates Efficacy and Tolerability in Treating Acute Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 9 Nov 2007
Planet Technologies Announces Completion of Antigen Laboratories Acquisition
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Oct 2007
Orexo Signs Distribution Agreement with Hospira in Asia for Pain Product Rapinyl(TM)
Biopharmaceuticals Distribution
 HSMN NewsFeed - 1 Oct 2007
Orexo Shows Positive Results in Completed Comparative Phase III Profile Study of the Sublinox(TM) Sleep Aid Involving Insomnia Patients
Biopharmaceuticals
 HSMN NewsFeed - 28 Sep 2007
Orexo: Orexo's Rapinyl(TM) Nearing Regulatory Decision in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Sep 2007
GelStat Strengthens Its Management Team With the Addition of William ("Bill") Colucci as Its President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Sep 2007
Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Jul 2007
Cobalis Reports Phase III Trial Results for PreHistin(TM) in Seasonal Allergic Rhinitis
Biopharmaceuticals
 HSMN NewsFeed - 22 Jun 2007
Optical Sensors Incorporated Changes Name to VASAMED, Inc.
Devices
 HSMN NewsFeed - 22 Jun 2007
TransOral Pharmaceuticals, Inc. Changes Name to Transcept Pharmaceuticals, Inc.
Biopharmaceuticals
 HSMN NewsFeed - 31 May 2007
Cobalis Announces Delay in Reporting of Phase III Trial Results for PreHistin(TM) in Seasonal Allergic Rhinitis
Biopharmaceuticals
 HSMN NewsFeed - 22 Mar 2007
Cobalis Completes Funding; Expects Top-Line Phase III Trial Results for PreHistin(TM) in April 2007
Biopharmaceuticals
 HSMN NewsFeed - 6 Mar 2007
TransOral Pharmaceuticals Raises $40 Million in Series D Financing. Proceeds Will Be Used to Complete Intermezzo(TM) Phase 3 Clinical Trials and File NDA
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Feb 2007
Cobalis' Mexican Patent for PreHistin(TM) Allowed
Biopharmaceuticals
 HSMN NewsFeed - 2 Feb 2007
Schering-Plough Cites Today's Anacor Agreement as Latest in Series of Deals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Oct 2006
SUBOXONE(R) (Buprenorphine/Naloxone) Approved In European Union for Treatment of Opioid Dependence
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 May 2006
Amarin Acquires Parkinson's Disease Drug Candidate
Biopharmaceuticals Neurology Acquisitions
Return to NewsFeed  

 Additional items found! 22

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 22 additional stories matching:
sublingual
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.